Comparison of Cocaine-Induced Vasoconstriction of Left and Right Coronary Arterial Systems

American Journal of Cardiology

Volumn 79, Issue 4, 1997, Pages 492-493

  Vongpatanasin, Wanpen ^a   Lange, Richard A ^a   Hillis, L David ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; SODIUM CHLORIDE; VASOCONSTRICTOR AGENT;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY BLOOD VESSEL; DRUG EFFECT; FEMALE; HEMODYNAMICS; HUMAN; INTRANASAL DRUG ADMINISTRATION; MALE; MIDDLE AGED; VASOCONSTRICTION;

ADMINISTRATION, INTRANASAL; ADULT; AGED; COCAINE; CORONARY VESSELS; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; SODIUM CHLORIDE; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 0031568422     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(96)00791-6     Document Type: Article

References (11)

1. Lange RA, Cigarroa RG, Yancy CW Jr, Willard JE, Popma JJ, Sills MN, McBride W, Kim AS, Hillis LD. Cocaine-induced coronary artery vasoconstriction. N Engl J Med 1989;321:1557-1562.
2. Lange RA, Cigarroa RG, Flores ED, McBride W, Kim AS, Wells PJ, Bedotto JB, Danziger RS, Hillis LD. Potentiation of cocaine-induced coronary vasoconstriction by beta-adrenergic blockade. Ann Intern Med 1990;112:897-903.
3. Flores ED, Lange RA, Cigarroa RG, Hillis LD. Effect of cocaine on coronary artery dimensions in atherosclerotic coronary artery disease: enhanced vasoconstriction at sites of significant stenoses. J Am Coll Cardiol 1990;16:74-79.
4. Brogan WC III, Lange RA, Kim AS, Moliterno DJ, Hillis LD. Alleviation of cocaine-induced coronary vasoconstriction by nitroglycerin. J Am Coll Cardiol 1991;18:581-586.
5. Brogan WC III, Lange RA, Glamann DB, Hillis LD. Recurrent coronary vasoconstriction caused by intranasal cocaine: possible role for metabolites. Ann Intern Med 1992;116:556-561.
6. Boehrer JD, Moliterno DJ, Willard JE, Hillis LD, Lange RA. Influence of labetalol on cocaine-induced coronary vasoconstriction in humans. Am J Med 1993;94:608-610.
7. Moliterno DJ, Willard JE, Lange RA, Negus BH, Boehrer JD, Glamann DB, Landau C, Rossen JD, Winniford MD, Hillis LD. Coronary artery vasoconstriction induced by cocaine, cigarette smoking, or both. N Engl J Med 1994;330:454-459.
8. Pirwitz MJ, Willard JE, Landau C, Lange RA, Glamann DB, Kessler DJ, Foerster EH, Todd E, Hillis LD. Influence of cocaine, ethanol, or their combination on epicardial coronary arterial dimensions in humans. Arch Intern Med 1995;155:1186-1191.
9. Reiber JHC, Serruys PW, Kooijman CJ, Wijns W, Slager CJ, Gerbrands JJ, Schuurbiers JCH, den Boer A, Hugenholtz PG. Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms. Circulation 1985; 71:280-288.
10. Winniford MD, Johnson SM, Mauritson DR, Rellas JS, Redish GA, Willerson JT, Hillis LD. Verapamil therapy for Prinzmetal's variant angina: comparison with placebo and nifedipine. Am J Cardiol 1982;50:913-918.
11. Yasue H, Takizawa A, Nagao M, Nishida S, Horie M, Kubota J, Omote S, Takaoka K, Okumura K. Long-term prognosis for patients with variant angina and influential factors. Circulation 1988;78:1-9.